Whole Shine Medical Technology Co., Ltd. (SHE:002622)
China
· Delayed Price · Currency is CNY 2.790
+0.030 (1.09%)
Apr 30, 2026, 11:25 AM CST
SHE:002622 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 702.9 | 861.13 | 756.62 | 500.6 | 167.98 | Upgrade
|
| Other Revenue | - | 0.44 | 0.09 | 0.05 | 0.13 | Upgrade
|
| Revenue | 702.9 | 861.57 | 756.71 | 500.65 | 168.11 | Upgrade
|
| Revenue Growth (YoY) | -18.42% | 13.86% | 51.14% | 197.82% | 47.02% | Upgrade
|
| Cost of Revenue | 389.48 | 445.21 | 371.42 | 292.54 | 91.1 | Upgrade
|
| Gross Profit | 313.42 | 416.36 | 385.29 | 208.11 | 77 | Upgrade
|
| Selling, General & Admin | 322.22 | 353.1 | 296.4 | 262.75 | 72.53 | Upgrade
|
| Research & Development | 11.76 | 10.11 | 15.9 | 14.57 | 9.85 | Upgrade
|
| Other Operating Expenses | -2.1 | -1.84 | -2.93 | -2.42 | -1.58 | Upgrade
|
| Operating Expenses | 331.88 | 364.74 | 311.88 | 277.74 | 81.44 | Upgrade
|
| Operating Income | -18.46 | 51.63 | 73.42 | -69.64 | -4.44 | Upgrade
|
| Interest Expense | - | -42.88 | -44.63 | -62.6 | -38.82 | Upgrade
|
| Interest & Investment Income | - | 1.33 | 19.96 | 12.43 | 1.23 | Upgrade
|
| Earnings From Equity Investments | -1.08 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -52.71 | -0.46 | -3.56 | -3.41 | -0.31 | Upgrade
|
| EBT Excluding Unusual Items | -72.25 | 9.62 | 45.19 | -123.21 | -42.34 | Upgrade
|
| Impairment of Goodwill | - | - | - | -21.19 | -14.72 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -3.7 | -91.79 | 66.39 | -17.43 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.71 | -0.58 | 4.17 | 0.88 | 0.03 | Upgrade
|
| Asset Writedown | -54.38 | -0.21 | -0.1 | -0.1 | - | Upgrade
|
| Legal Settlements | - | -13.46 | -13.42 | -215.27 | - | Upgrade
|
| Other Unusual Items | - | -0.96 | 1.84 | 2.56 | 4.59 | Upgrade
|
| Pretax Income | -125.92 | -9.29 | -54.11 | -289.94 | -69.86 | Upgrade
|
| Income Tax Expense | 4.01 | 5.95 | 4.15 | -9.73 | 3.97 | Upgrade
|
| Earnings From Continuing Operations | -129.93 | -15.24 | -58.26 | -280.22 | -73.83 | Upgrade
|
| Minority Interest in Earnings | 10.5 | -22.45 | -36.11 | 23.43 | -2.15 | Upgrade
|
| Net Income | -119.42 | -37.69 | -94.37 | -256.79 | -75.98 | Upgrade
|
| Net Income to Common | -119.42 | -37.69 | -94.37 | -256.79 | -75.98 | Upgrade
|
| Shares Outstanding (Basic) | 840 | 839 | 840 | 840 | 844 | Upgrade
|
| Shares Outstanding (Diluted) | 840 | 839 | 840 | 840 | 844 | Upgrade
|
| Shares Change (YoY) | 0.04% | -0.10% | 0.03% | -0.50% | 0.50% | Upgrade
|
| EPS (Basic) | -0.14 | -0.04 | -0.11 | -0.31 | -0.09 | Upgrade
|
| EPS (Diluted) | -0.14 | -0.04 | -0.11 | -0.31 | -0.09 | Upgrade
|
| Free Cash Flow | 44.12 | 78.57 | 103.4 | 8.26 | 12.63 | Upgrade
|
| Free Cash Flow Per Share | 0.05 | 0.09 | 0.12 | 0.01 | 0.01 | Upgrade
|
| Gross Margin | 44.59% | 48.33% | 50.92% | 41.57% | 45.81% | Upgrade
|
| Operating Margin | -2.63% | 5.99% | 9.70% | -13.91% | -2.64% | Upgrade
|
| Profit Margin | -16.99% | -4.38% | -12.47% | -51.29% | -45.20% | Upgrade
|
| Free Cash Flow Margin | 6.28% | 9.12% | 13.66% | 1.65% | 7.51% | Upgrade
|
| EBITDA | -0.79 | 69.89 | 91.12 | -50.55 | 7.57 | Upgrade
|
| EBITDA Margin | -0.11% | 8.11% | 12.04% | -10.10% | 4.50% | Upgrade
|
| D&A For EBITDA | 17.67 | 18.26 | 17.71 | 19.09 | 12.01 | Upgrade
|
| EBIT | -18.46 | 51.63 | 73.42 | -69.64 | -4.44 | Upgrade
|
| EBIT Margin | -2.63% | 5.99% | 9.70% | -13.91% | -2.64% | Upgrade
|
| Revenue as Reported | - | 861.57 | 756.71 | 500.65 | - | Upgrade
|
| Advertising Expenses | - | 115.09 | 104.5 | 94.22 | 8.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.